期刊文献+

两种疗法根治幽门螺杆菌的疗效比较 被引量:1

Comparison with the curative effects for two therapies to affect a radical cure of Hp affection
原文传递
导出
摘要 目的:评价益生菌联用质子泵抑制剂治疗由幽门螺杆菌感染所致消化性溃疡的疗效。方法:选择临床确诊的由幽门螺杆菌感染所致的消化性溃疡患者96例,分A、B组。A组50例,给予双歧四联活菌剂+奥美拉唑;B组46例,给予克拉霉素+甲硝唑+奥美拉唑。结果:A组幽门螺杆菌根除的有效率和根除率分别为84.0%,88.0%,B组分别为91.3%,89.1%,2组比较差异无显著性(P>0.05);不良反应发生率:A组为4.0%,B组为32.6%,2组有显著差异(P<0.05)。结论:益生菌联合质子泵抑制剂治疗Hp感染安全、有效,值得推广。 OBJECTIVE To evaluate the curative effect of probiotics combined with PPI to treat peptic ulcer caused by Helicobacter pylori (Hp). METHODS 96 clinical cases were selected with a definite diagnosis of peptic ulcer caused by Hp, and di- vided into group A and B. Group A, with 50 cases, was given combined Bifidobacteriura, Lactobacillus, Enterococcus and Bacillus cereus tables and omeprazole (OME) ; while group B,with 46 cases,was given CLA, metronidazole (MTZ) and OME. RESULTS The effective rate and eradication rate of Hp affection for group A was 84. 0% and 88. 0% respectively; the effective rate and eradication rate for group B was 91.3% and 89. 1% respectively. There was no significant difference between two groups (P〉0. 05) ; while the occurrence rate of adverse reaction was 4. 0% for Group A and 32. 6% for Group B, and two groups have significant differences (P〈0. 05). CONCLUSION The treatment of HP affection using probiotics combined with PPI was safe and effective,which can be widely used in clinic.
作者 陆学工
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第4期315-316,共2页 Chinese Journal of Hospital Pharmacy
关键词 益生菌制剂 质子泵抑制剂 幽门螺杆菌 probiotic preparation proton pump inhibitors Helicobacter pylori
  • 相关文献

参考文献8

二级参考文献90

共引文献188

同被引文献19

  • 1吕农华涕四届全国幽门螺杆茵共识解读[J].2012中国消化系疾病学术大会,2012.
  • 2Xu S, Wan X, Zheng X, et al. Symptom improvement after helicobacter pylori eradication in patients with functional dyspepsia- A multicenter, randomized, prospective cohort study [J]. Int J Clin Exp Med, 2013, 6(9): 747-756.
  • 3Saniee P, Siavoshi F, Nikbakht Broujeni G, et al. Immunodetection of Helicobacter pylori-specific Proteins in Oral and Gastric Candida Yeasts[J]. Arch Iran Med, 2013, 16(11): 624-630.
  • 4An B, Moon BS, Kim H, et al. Antibiotic Resistance in Helicobacter pylori Strains and its Effect on H. pylori Eradication Rates in a Single Center in Korea[J]. Ann Lab Med, 2013, 33(6): 415-419.
  • 5Smiley R, Bailey J, Sethuraman M, et al. Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori[J]. J Microbiol, 2013, 51 (5): 612-618.
  • 6Moon SH, Lee JH, Kim KT, et al. Antimicrobial Effect of 7-0- Butylnaringenin, a Novel Flavonoid, and Various Natural Flavonoids against Helicobacter pylori Strains [J]. Int J Environ Res Public Health, 2013, 10(11): 5459-5469.
  • 7Iqbal S, Fatima S, Raheem A, et al. Agreement Between Serology and Histology for Detection of Helicobacter pylori Infection [J]. J Coil Physicians Surg Pak, 2013, 23(10): 784-786.
  • 8Moretti E, Collodel G, Mazzi L, et al. CagA-Positive Helicobac ter pylori Infection and Reduced Sperm Motility, Vitality, and Normal Morphology[J]. Dis Markers, 2013, 35(4): 229-234.
  • 9Hsiang J, Selvaratnam S, Taylor S, et al. Increasing primary antibiotic resistance and ethnic differences in eradication rates of Helicobacter pylori infection in New Zealand-a new look at an old enemy [J]. N Z Med J, 2013, 126(1384): 64-76.
  • 10Nasa M, Choksey A, Phadke A, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized study[J]. Indian J Gastroenterol, 2013, 32(6): 392-396.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部